BioLife Historical Financial Ratios

BLFS Stock

USD 21.25 0.21 1.00%

BioLife Solutions is presently reporting on over 114 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0014, PTB Ratio of 3.26 or Days Sales Outstanding of 38.65 will help investors to properly organize and evaluate BioLife Solutions financial condition quickly.

Quick Ratio Current Ratio

Build AI portfolio with BioLife Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

About BioLife Financial Ratios Analysis

BioLife SolutionsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate BioLife Solutions investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on BioLife financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across BioLife Solutions history.

BioLife Solutions Financial Ratios Chart

At this time, BioLife Solutions' EV To Operating Cash Flow is comparatively stable compared to the past year. EV To Free Cash Flow is likely to gain to 228.14 in 2025, whereas PTB Ratio is likely to drop 3.26 in 2025.

Price To Sales Ratio Dividend Yield Days Sales Outstanding Average Payables

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing BioLife Solutions stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on BioLife Solutions sales, a figure that is much harder to manipulate than other BioLife Solutions multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is BioLife Solutions dividend as a percentage of BioLife Solutions stock price. BioLife Solutions dividend yield is a measure of BioLife Solutions stock productivity, which can be interpreted as interest rate earned on an BioLife Solutions investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Most ratios from BioLife Solutions' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into BioLife Solutions current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLife Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.At this time, BioLife Solutions' EV To Operating Cash Flow is comparatively stable compared to the past year. EV To Free Cash Flow is likely to gain to 228.14 in 2025, whereas PTB Ratio is likely to drop 3.26 in 2025.

	2024	2025 (projected)
Dividend Yield	0.002006	0.001426
Price To Sales Ratio	14.54	13.81

Dividend Yield Price To Sales Ratio

BioLife Solutions fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding
Price To Sales Ratio		-0.23	1.0	0.89	-0.18	0.15	-0.61	-0.16	-0.29	1.0	1.0	-0.52	-0.2	0.69	0.06	-0.33	-0.38	0.29	0.28	-0.22	-0.37	-0.01	-0.25	-0.03	-0.23	-0.21
Dividend Yield	-0.23		-0.23	0.01	0.76	0.49	0.32	0.29	-0.39	-0.23	-0.23	0.2	0.65	-0.39	-0.2	0.42	0.5	0.43	-0.4	0.57	-0.06	0.17	0.9	-0.34	0.44	-0.24
Ptb Ratio	1.0	-0.23		0.89	-0.19	0.14	-0.62	-0.16	-0.29	1.0	1.0	-0.52	-0.2	0.69	0.06	-0.34	-0.38	0.29	0.29	-0.22	-0.37	-0.01	-0.26	-0.03	-0.24	-0.21
Days Sales Outstanding	0.89	0.01	0.89		-0.03	0.02	-0.66	-0.18	-0.36	0.89	0.89	-0.61	-0.22	0.55	-0.05	-0.27	-0.4	0.27	0.22	-0.18	-0.5	-0.05	-0.08	-0.28	-0.14	-0.05
Book Value Per Share	-0.18	0.76	-0.19	-0.03		0.43	0.22	0.12	-0.46	-0.19	-0.19	0.08	0.67	-0.46	-0.31	0.36	0.36	0.66	-0.31	0.75	-0.27	-0.12	0.87	-0.58	0.38	-0.35
Free Cash Flow Yield	0.15	0.49	0.14	0.02	0.43		0.49	0.24	-0.37	0.14	0.15	0.44	0.75	0.18	0.02	0.08	0.23	0.36	-0.37	0.38	0.21	0.21	0.56	0.23	0.18	-0.48
Operating Cash Flow Per Share	-0.61	0.32	-0.62	-0.66	0.22	0.49		-0.02	0.05	-0.62	-0.61	0.96	0.5	-0.41	0.26	0.39	0.16	-0.09	-0.44	0.45	0.64	0.23	0.45	0.49	0.48	-0.04
Average Payables	-0.16	0.29	-0.16	-0.18	0.12	0.24	-0.02		0.19	-0.16	-0.16	-0.1	0.49	0.03	-0.03	0.03	0.35	0.13	0.18	0.07	0.05	-0.03	0.06	-0.03	-0.05	-0.08
Capex To Depreciation	-0.29	-0.39	-0.29	-0.36	-0.46	-0.37	0.05	0.19		-0.29	-0.29	-0.07	-0.34	-0.1	0.08	-0.16	-0.17	-0.53	0.73	-0.33	-0.04	-0.04	-0.46	0.25	-0.19	0.45
Pb Ratio	1.0	-0.23	1.0	0.89	-0.19	0.14	-0.62	-0.16	-0.29		1.0	-0.52	-0.2	0.69	0.06	-0.34	-0.38	0.29	0.29	-0.22	-0.37	-0.01	-0.26	-0.03	-0.24	-0.21
Ev To Sales	1.0	-0.23	1.0	0.89	-0.19	0.15	-0.61	-0.16	-0.29	1.0		-0.52	-0.2	0.69	0.06	-0.34	-0.38	0.29	0.28	-0.22	-0.37	-0.01	-0.25	-0.03	-0.23	-0.21
Free Cash Flow Per Share	-0.52	0.2	-0.52	-0.61	0.08	0.44	0.96	-0.1	-0.07	-0.52	-0.52		0.44	-0.35	0.42	0.44	0.09	-0.07	-0.55	0.37	0.76	0.31	0.35	0.58	0.5	-0.03
Roic	-0.2	0.65	-0.2	-0.22	0.67	0.75	0.5	0.49	-0.34	-0.2	-0.2	0.44		-0.25	0.02	0.36	0.36	0.52	-0.38	0.7	0.23	0.16	0.72	-0.03	0.41	-0.36
Inventory Turnover	0.69	-0.39	0.69	0.55	-0.46	0.18	-0.41	0.03	-0.1	0.69	0.69	-0.35	-0.25		0.02	-0.67	-0.24	-0.29	0.17	-0.44	-0.11	0.0	-0.48	0.3	-0.67	-0.22
Net Income Per Share	0.06	-0.2	0.06	-0.05	-0.31	0.02	0.26	-0.03	0.08	0.06	0.06	0.42	0.02	0.02		0.26	-0.38	-0.09	0.0	-0.05	0.38	0.14	-0.19	0.49	0.3	0.33
Days Of Inventory On Hand	-0.33	0.42	-0.34	-0.27	0.36	0.08	0.39	0.03	-0.16	-0.34	-0.34	0.44	0.36	-0.67	0.26		-0.02	0.42	-0.25	0.29	0.43	-0.1	0.5	0.04	0.75	0.33
Payables Turnover	-0.38	0.5	-0.38	-0.4	0.36	0.23	0.16	0.35	-0.17	-0.38	-0.38	0.09	0.36	-0.24	-0.38	-0.02		0.12	-0.42	0.33	-0.03	0.33	0.42	-0.19	-0.08	-0.62
Average Inventory	0.29	0.43	0.29	0.27	0.66	0.36	-0.09	0.13	-0.53	0.29	0.29	-0.07	0.52	-0.29	-0.09	0.42	0.12		-0.16	0.53	-0.18	0.04	0.56	-0.43	0.46	-0.41
Capex To Revenue	0.28	-0.4	0.29	0.22	-0.31	-0.37	-0.44	0.18	0.73	0.29	0.28	-0.55	-0.38	0.17	0.0	-0.25	-0.42	-0.16		-0.27	-0.37	-0.32	-0.48	-0.01	-0.22	0.39
Cash Per Share	-0.22	0.57	-0.22	-0.18	0.75	0.38	0.45	0.07	-0.33	-0.22	-0.22	0.37	0.7	-0.44	-0.05	0.29	0.33	0.53	-0.27		0.04	0.12	0.72	-0.19	0.5	-0.45
Pocfratio	-0.37	-0.06	-0.37	-0.5	-0.27	0.21	0.64	0.05	-0.04	-0.37	-0.37	0.76	0.23	-0.11	0.38	0.43	-0.03	-0.18	-0.37	0.04		0.04	0.04	0.8	0.4	0.16
Interest Coverage	-0.01	0.17	-0.01	-0.05	-0.12	0.21	0.23	-0.03	-0.04	-0.01	-0.01	0.31	0.16	0.0	0.14	-0.1	0.33	0.04	-0.32	0.12	0.04		0.17	0.08	-0.13	-0.41
Payout Ratio	-0.25	0.9	-0.26	-0.08	0.87	0.56	0.45	0.06	-0.46	-0.26	-0.25	0.35	0.72	-0.48	-0.19	0.5	0.42	0.56	-0.48	0.72	0.04	0.17		-0.29	0.52	-0.31
Capex To Operating Cash Flow	-0.03	-0.34	-0.03	-0.28	-0.58	0.23	0.49	-0.03	0.25	-0.03	-0.03	0.58	-0.03	0.3	0.49	0.04	-0.19	-0.43	-0.01	-0.19	0.8	0.08	-0.29		0.09	0.13
Pfcf Ratio	-0.23	0.44	-0.24	-0.14	0.38	0.18	0.48	-0.05	-0.19	-0.24	-0.23	0.5	0.41	-0.67	0.3	0.75	-0.08	0.46	-0.22	0.5	0.4	-0.13	0.52	0.09		0.21
Days Payables Outstanding	-0.21	-0.24	-0.21	-0.05	-0.35	-0.48	-0.04	-0.08	0.45	-0.21	-0.21	-0.03	-0.36	-0.22	0.33	0.33	-0.62	-0.41	0.39	-0.45	0.16	-0.41	-0.31	0.13	0.21

Click cells to compare fundamentals

BioLife Solutions Account Relationship Matchups

BioLife Solutions fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	22.65	12.04	4.78	4.96	14.54	13.81
Ptb Ratio	5.31	2.99	(3.13)	2.1	3.43	3.26
Days Sales Outstanding	60.77	71.12	76.57	47.53	40.68	38.65
Book Value Per Share	7.52	12.49	8.57	7.72	7.57	7.95
Free Cash Flow Yield	0.001728	(0.009213)	(0.0244)	(0.0266)	0.004352	0.004569
Operating Cash Flow Per Share	0.0623	0.24	(0.13)	(0.29)	0.18	0.19
Capex To Depreciation	0.91	0.65	0.63	0.52	0.37	0.35
Pb Ratio	5.31	2.99	(3.13)	2.1	3.43	3.26
Ev To Sales	11.32	21.0	11.68	5.01	13.75	13.06
Free Cash Flow Per Share	0.11	0.0276	0.0689	(0.34)	(0.43)	0.12
Roic	0.0674	(0.0171)	(0.0932)	(0.19)	(0.0187)	(0.0197)
Inventory Turnover	0.8	1.78	2.87	3.09	2.22	0.84
Days Of Inventory On Hand	205.11	127.09	118.03	164.33	432.2	238.03
Payables Turnover	5.62	5.45	7.02	13.91	6.86	3.58
Capex To Revenue	0.0963	0.0704	0.0642	0.0445	0.0392	0.0373
Cash Per Share	3.31	1.81	1.48	1.18	2.27	2.38
Pocfratio	167.19	(296.74)	(91.08)	(56.84)	141.85	148.94
Interest Coverage	(185.11)	(62.61)	(58.1)	(39.09)	(9.92)	(10.41)
Capex To Operating Cash Flow	0.71	(1.73)	(1.22)	(0.51)	0.38	0.28
Pfcf Ratio	578.77	(108.54)	(40.96)	(37.63)	229.8	241.29
Days Payables Outstanding	64.92	67.01	51.97	26.24	53.23	50.56
Income Quality	2.44	0.63	0.0607	0.19	(0.42)	(0.4)
Roe	0.013	(0.0174)	0.57	(0.2)	(0.0578)	(0.0607)
Ev To Operating Cash Flow	155.02	(287.85)	(93.94)	(57.43)	134.11	140.82
Pe Ratio	408.42	(171.18)	(5.53)	(10.69)	(59.25)	(56.29)
Return On Tangible Assets	0.0184	(0.0477)	(0.72)	(0.4)	(0.11)	(0.12)
Ev To Free Cash Flow	536.63	(105.29)	(42.25)	(38.02)	217.27	228.14
Earnings Yield	0.002448	(0.005842)	(0.18)	(0.0935)	(0.0169)	(0.0177)
Net Debt To E B I T D A	(74.11)	2.42	(1.05)	(0.16)	(42.57)	(40.44)
Current Ratio	3.11	7.37	3.15	2.86	4.54	3.32
Tangible Book Value Per Share	4.24	2.7	2.53	2.1	2.76	2.9
Receivables Turnover	6.01	5.13	4.77	7.68	8.97	8.15
Shareholders Equity Per Share	7.52	12.49	(5.81)	7.72	7.57	7.95

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Graham Number
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

BioLife Historical Financial Ratios

About BioLife Financial Ratios Analysis

BioLife Solutions Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Average Payables

BioLife Solutions fundamentals Correlations

BioLife Solutions Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BioLife Solutions fundamentals Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for BioLife Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ptb Ratio	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Price To Sales Ratio
Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Ev To Sales	+ 1.0	Ptb Ratio
Ev To Sales	+ 1.0	Pb Ratio

Pfcf Ratio	- 0.67	Inventory Turnover
Days Of Inventory On Hand	- 0.67	Inventory Turnover
Operating Cash Flow Per Share	- 0.66	Days Sales Outstanding
Days Payables Outstanding	- 0.62	Payables Turnover
Pb Ratio	- 0.62	Operating Cash Flow Per Share
Operating Cash Flow Per Share	- 0.62	Ptb Ratio